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General Clinical
Research Center

Got Research?
We’ve got resources!
UNM faculty, staff, and
students of the medical,
nursing, pharmacy, physical
and occupational therapy
schools are eligible to receive
support from the GCRC for
clinical research. The GCRC
offers the following forms of
support:

• Financial
• Inpatient Beds
• Outpatient Clinic
• Laboratory Services
• Bionutrition
• Informatics
• Nurse Practitioner
• Registered Nurses
• Pharmacist
• Biomedical Research
Consultation

Call 272-2366 and begin your
application process today!
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Congratulations Glenn T. Peake Award Recipients!

The General Clinical Research
Center Clinical Investigator
Award was established in
December 1986 to recognize
excellence in achievement in
the area of research, one of the
critical missions of the School
of Medicine. The late Dr. Glenn
T. Peake, who initiated the UNM
General Clinical Research Center,
started this program in 1986.
He was the first Program Director
of the GCRC from May of 1976,
and held that position up to his
death.
Dr. Peake was an endocrinologist
who specialized in pediatric
endocrinology, and the focus
of his research was on growth
hormone and prolactin. He
trained under Dr. Bill Daughaday,
who discovered sulfation
factor, which was later found
to be somatomedin-C, later
called IGF-1. At the time that
Dr. Peake trained, IGF-1 was
assayed by the sulfation factor
assay because there was no
radioimmunoassay for the
hormone at that time. Similarly,
prolactin was assayed using
the pigeon crop assay because
there was no radioimmunoassay

for prolactin at that time. Dr
Peake was a beloved professor,
clinician, and teacher, who
helped transition endocrinology
from the bioassay era into the
radioimmunoassay era.
In memory of Dr. Peake, the title
of the Clinical Investigatror Award
was changed to the “Glenn T.
Peake Award”.

1998 Mark Schuyler
1999 Jerry Shih
2000 Mark Rohrscheib
2001 Kristi Watterberg
2002 Debra Waters
2003 Mark Burge
2004 Robin Ohls
Over recent years, the GCRC
award program has been deemphasized, but under the
leadership of the new Program
Director Mark Burge, M.D.,
the program has been brought
back into existence so that

GCRC investigators can be
recognized for their outstanding
achievements. On May 27,
2005, seven people were
recognized in arrears as Glenn
T. Peak Award recipients for
the years 1998-2004. These
individuals were recognized for
their outstanding achievement
in clinical and translational
research on the UNM GCRC.
The award winner is determined
based upon peer review by the
GCRC Advisory Committee.
Factors determining eligibility
for the award include GCRC
utilization, publications, national
and regional reputation as
an independent investigator,
and successful attainment of
peer-reviewed grant funding.
In order to qualify for the
award, the investigator needs
to have an approved GCRC
protocol and must be a clinical
researcher. He/she must also
use the GCRC resources in a
significant way and must be a
productive scientist. Successful
mentorship of trainees
also contributes to award
determination.
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On the
Lighter Side
Q: What did the apple
say to the banana?
A: Nothing, apples can't
talk.
Q: What nationality are
you when you go to the
bathroom?
A: European.
Q: What do you call
cheese that’s not yours?
A: Nacho cheese.
Q: How do you catch a
unique rabbit?
A: Unique up on him.
(Jokes courtesy of Cole
Burge, eight-year old
son of GCRC Director,
Mark Burge, MD)

GCRC

From the Director
Summer is nearly here, and I
hope you are all busy making
plans to have a great time. My
summer will include travel to
San Diego for the American
Diabetes Association scientific
meeting, one week at diabetes
camp taking care of 75 children
with type 1 diabetes while we
swim, play volleyball and “enjoy”
capture the flag. I will also be
traveling to Ashland, Oregon
to give a presentation at the
Ashland Metabolism Meeting for
one of my buddies from medical
school who is organizing the
affair. No, I don’t get paid for it,
but I do get free tickets to the
Ashland Shakespearean Festival
(yahoo, methinks). Somewhere
in there, I also need to plan a
vacation.
Oh yeah, and there is also the
GCRC to think about. Going
into our renewal year next year,
it is critical that we maintain
inpatient and outpatient
censuses as high as possible

I attended a conference in
Washington in late May that
was sponsored by NIH and
that was entitled “Enhancing
the Discipline of Clinical and
Translational Sciences.”
The idea was that clinician
researchers are undervalued by
the current academic system,
and that careers are beginning
to suffer because of this neglect.
The conference was designed
to explore ideas about: “What
should a home for clinical and
translational research look like?”
Should it be a discrete academic
department? Should it take the

form of a freestanding institute
under the larger university
umbrella? Should a high-ranking
university official, such as a
“Vice President for Clinical and
Translational research”, oversee
the clinical and translational
research enterprise?
Institutions around the
country are trying all of these
approaches with varying degrees
of success, but at UNM we have
not yet begun to wrestle with this
problem. This is partly because
the pool of successful clinical
and translational researchers
at UNM is so small, and partly
this is because nobody is
complaining too loudly about
the existing system at present.
Regardless, it is clear that
changes in the mechanisms
for supporting clinical and
translational research are going
to be coming down from NIH,
and we need to be ready to
adapt.
cont. page 4

Bionutrition Publication
In January, a manuscript by
Rosemary Wold, MS, RD, LD
(Bionutrition Manager) and
colleagues was published
as the feature article in the
Journal of the American Dietetic
Association.
In this manuscript there was a
retrospective review of the use
of 22 non-vitamin, non-mineral
(NVNM) supplements. These
included, for example: flax
seed oil, chondroitin sulfate,
chromium picolinate, creatine
preparations, fish and cod
liver oils, garlic, ginkgo biloba,
glucosamine, hawthorn,
melatonin, St. John’s Wort, and
shark cartilage. Concurrent use
of prescription and over-thecounter (OTC) medications was
examined in participants of the
New Mexico Aging Process Study
from 1994-1999.

Rosenary Wold, MS, RD, LD

through the usually slow
summer months. Encourage
the investigators you work with
to remain active, and try to
go out of your way to facilitate
their research efforts. It may
not always seem like it, but the
outreach and “PR” activities
practiced by GCRC staff are
noted and appreciated by
investigators.

by Mark R. Burge, MD

Supplement and medication

records for an average of 359
male (36%) and female (64%)
participants age 60 to 99 years
were reviewed annually. Over
the six years of the study, NVNM
supplement usage steadily
increased with both women
and men showing a three-fold
increase from 14.42% in 1994
to 45.62% in 1999 for women,
and from 11.72% in 1994 to
41.46 % in 1999 for men. By
1999, glucosamine, emerged as
the most frequently used NVNM
supplement followed by ginkgo
biloba, chondroitin and garlic.
For women, there was a
significant linear trend (p<0.05)
over time for 12 supplements:
black cohosh, borage, evening
primrose, flax oils, chondroitin,
DHEA, garlic, ginkgo biloba,
glucosamine, grapeseed extract,
hawthorn, and St. John’s Wort.
For men, three supplements
showed a significant linear trend

(p<0.05): alpha lipoic acid,
ginkgo biloba, and grapeseed
extract. Potential interactions
between supplements and
medications were seen for 10 of
the 22 supplements surveyed
with a total of 142 potential
interactions observed over the
6-year period. A statistically
significant increasing trend was
seen in potential interactions
between supplements and
prescription medications
- 11.9% in 1994 to 30.6%
in 1999 (p<0.05). The
combination of ginkgo biloba
with aspirin was reported once
in 1994 and 20 times in 1999.
Citation: RS Wold, ST Lopez , CL Yau,
L Butler, SL Pareo, DL Waters, PJ
Garry, RN Baumgartner, Increasing
Trends in Elderly Persons’ Use of
Nonvitamin Nonmineral Dietary
Supplements and Concurrent Use
of Medications”, J. Amer. Dietetic
Assoc., 2005, 105: 54-63.
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Glenn T. Peake Award Recipients (cont. from page 1)
1998 Mark Schuyler, MD
Dr. Schuyler has been with UNM
since 1986 as a Professor in the
Department of Internal Medicine.
He has been continually funded as
a Principle Investigator by the VA
Merit Review system and the NIH for
27 years, including 2 RO1s, and is
actively involved in the NIH review
process. He currently has 4 active
protocols in the GCRC. He and his
colleagues published the first widely
read paper in the medical literature
describing the interaction of asthma
and T cells in the New England
Journal of Medicine.
1999 Jerry Shih, MD
Dr. Shih has been with UNM since
1993 as a faculty
member in the
Department of
Neurology as well
as the Department
of Neurosciences
since 1999.
He is Director
of the UNM
Comprehensive
Epilepsy Program
and currently
Associate
Professor
of Neurology and
Neurosciences. He received
a NIH/NCRR CAP award
from 1996-2002, and is
the Principal Investigator on
one of four studies funded through
the NIH NCRR Center of Biomedical
Research Excellence (COBRE). He
currently has two active protocols in
the GCRC.
2000 Mark Rohrscheib, MD
Dr. Rohrscheib recently rejoined the
Department of Internal Medicine
faculty after a two year leave of
absence to complete a fellowship
in Nephrology. He has received
over ten years of extramural
funding for research conducted
as medical director of a local
bioengineering start-up company

that began on North campus as a
research effort between the UNM
and Sandia National Laboratories.
He has conducted a number of
studies on the UNM GCRC in
support of the development of
methods to noninvasively measure
blood glucose using near-infrared
spectroscopy.
2001 Kristi Watterberg, MD
Dr. Watterberg returned to UNM in
July 2000 as a neonatologist and
faculty member in the Department
of Pediatrics. She has previously
received funding as a principal
investigator from the Maternal and
Child Health Research Bureau of
the Public Health Service, and has
received
several

smaller grants. She is
currently the principal investigator
for a multicenter clinical trial funded
by the NIH. She was first supported
by the UNM GCRC when she was
a neonatology fellow in 1983, and
currently has 3 active protocols in
the GCRC. This award is particularly
meaningful to her: when she was
first supported by the GCRC as a
neonatal fellow, it was Dr. Peake
who came out of the room and let
her know the advisory committee
had approved the project!
2002 Debra Waters, PhD

Dr. Waters has been a Research
Assistant Professor since 1998.
She received her PhD in Exercise
Physiology at UNM in 1993. Her
primary research interests include
the role of age-related mitochondrial
damage and the development
of sarcopenia and assessing
dysregulation of sex steroid
metabolism and growth factors in
aging. She is evaluating the utility of
magnetic resonance spectroscopy
in assessing mitochondrial function
in skeletal muscle and works closely
with Richard Baumgartner as the
Assistant Director of the Clinical
Nutrition Program.
2003 Mark Burge, MD
Dr. Burge has been with UNM
since 1993 as an Endocrinologist
and as a faculty member in the
Department of Internal Medicine. He
has previously received a NCRR CAP
award from 1996-1999, and was an
NIDDK K-23 recipient
in 2001. He is
currently the principal
investigator on his
first R01, examining
the role of ethanol in
the pathogeneisis of
overnight hypoglycemia
in patients with type 2
diabetes. He currently
has 5 active protocols in
the GCRC.
2004 Robin Ohls, MD
Dr. Ohls has been with UNM since
1995 as a Neonatologist and
faculty member in the Department
of Pediatrics. She has previously
received a K-23 award, and was an
NIDDK Institutional Development
Award recipient in 1998. She was
the principal investigator for 2
NICHD Neonatal Network studies on
the use of erythropoietin in preterm
infants. She currently has 4 active
protocols in the GCRC. In addition,
she received the Champion of
Advocacy Award from the American
Society of Hematology in 2004.

GCRC Contacts
Administration

272-2366

Mark Burge, MD
Program Director
Mark Schuyler, MD
Associate Program Director
Selina Keryte, BA
Administrative Director
Sandy McClelland, CFNP
Manager Clinical Operations
Irene Williams
Administrative Coordinator
Fax

Informatics

272-0266

272-2523

Lori Sloane
Systems Manager
Clifford Qualls, PhD
Biostatistician
Ronald Schrader, PhD
Biostatistician

RSA

272-6817

Peggy Jennings, PhD
Research Subject Advocate

Outpatient Clinic 272-2451
Patsy Lucero
Administrative Assistant

Inpatient Unit

272-2770

Lorraine Martinez, RN, MSN
Nurse Manager 5East

Peds Research

272-0916

Lu-ann Papile, MD
Associate Program Director
Connie Backstrom, RN, CCRC
Nurse Manager

Core Lab

272-3619

David S. Schade, MD
Core Lab Director
Tony Brazfield, MT, ASCP
Laboratory Manager
Bill McCurdy, BS
Research Technician III

Nutrition

272-5501

Rosemary Wold, RD
Nutrition Manager

Pharmacy
Nancy Morgan, RPh
Pharmacist

272-2515
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From the Director
Of course, the meeting was
interesting and, at times,
raucous. Many of the attendees
were GCRC officials and
Program Directors who tried to
argue (mostly unsuccessfully)
that a home for clinical and
translational research already
exists, and it is called a GCRC.

(cont. from page 2)
People argued in response that
GCRCs are too restricted in their
mechanisms of support, tend
to have a narrow focus on one
or two disease states, and have
not effectively advocated for
protecting the time and careers
(i.e.- promotion and tenure) of
their investigators. Many of

Pediatric Research Showcase
The Department of Pediatrics
Research Day was held
Thursday, May 12th and
provided investigators with an
opportunity to showcase their
current research and creative
works. Our Pediatric Nurse/
Clinical Trial Coordinators were
pleased to see that our hard
work at screening, recruiting
and coordinating resulted in the
following GCRC protocols being
featured as slide presentations:

Kristi Watterberg, MD &
Michele Shaffer, PhD :
“Cortisol Concentrations and
Apparent Serum Half-Life
During Hydrocortisone Therapy
in Extremely Low Birth Weight
Infants”
Robert Annett, PhD, Janet
Brody, PhD, & David Scherer,
PhD:
“Perceptions of Risk Associated
with Asthma Research
Procedures Among Children,

the people around the room
felt like responding to the “new
mechanism,” whatever it turns
out to look like, will be the only
way to increase GCRC budgets
in the near future. The anxiety
level in the room among GCRC
proponents was best described
as “high.”

General Clinical
Research Center
UNM Hospital
5th Floor, East Wing
MSC 10 5540
2211 Lomas Blvd NE
Albuquerque, NM
87131-5191

Parents and Pediatricians”
Margaret Armstrong, MD,
Sandra Whisler, MD, John
Chimarusti, PhD, LMSW &
Robert Annett, PhD:
“Neurobehavioral Respite:
Evaluating Effects Upon Parent
Caregivers”
Congratulations to all! The
successes and achievements of
our GCRC Pediatric Investigators
are important to all of us.

Introducing... Ron Schrader, GCRC Biostatistician

Ron Schrader, Ph.D.
Biostatistician

I have been a faculty member in
the Department of Mathematics
and Statistics at the University
of New Mexico for twenty-nine
years, including a long detour
into administration as Chair
of the department. For the
first half of my tenure in Math
and Stat I had an office next
to Professor Clifford Qualls.
We shared many interests
then, and still do. I am a
biostatistician and now share
the biostatistician’s office (parttime) in the GCRC with Clifford.

General Clinical Research Center
University of New Mexico
505-272-2366

I still have a full-time
appointment in Mathematics
and Statistics. I have taken
over some of the computeroriented applied courses in the
department, and will be teaching
Data Analysis I (Stat 527) and
Biostatistics for MPH I (Stat
538), both using Minitab, in the

fall. In the spring I will teach
Data Analysis II (Stat 528) using
SAS and Biostatistics for MPH
(Stat 539) using Stata. We have
all this software and a lot more
(such as Splus) in the GCRC.
The role we biostatisticians play
is to assist with: protocol design,
sample size and power analysis,
randomization issues, statistical
analysis, writing statistical
methodology and results,
and responding to referees.
During the summer (except
July when I will be gone), I am
here Mondays and Thursdays;
beginning in the fall I will be
here on Monday afternoons and
Thursday mornings. I am a less
booked up than Clifford is, so
you should be able to see me
sooner - please stop by or mail
rschrader@salud.unm.edu !

GCRC News is
published quarterly
by the UNM GCRC.
Please submit
requests, comments
and questions to
Sarah Sanders, RN
272-2451
Photography:
Mary Pat Leonard, RN

